002198 ST嘉应制药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.7204.1292.7104.6026.219
总资产报酬率 ROA (%)1.4303.6112.4444.0515.313
投入资产回报率 ROIC (%)1.6133.9272.5834.3605.754

边际利润分析
销售毛利率 (%)45.89359.94059.93265.21065.332
营业利润率 (%)10.60110.3876.7147.5988.174
息税前利润/营业总收入 (%)10.7009.8016.3076.9927.471
净利润/营业总收入 (%)10.1347.9425.4796.4366.665

收益指标分析
经营活动净收益/利润总额(%)104.385115.807107.51696.055108.449
价值变动净收益/利润总额(%)-5.738-3.9882.6902.8151.304
营业外收支净额/利润总额(%)0.334-5.033-0.648-2.900-5.454

偿债能力分析
流动比率 (X)4.2495.21512.15311.7596.720
速动比率 (X)3.7984.44710.28610.0445.728
资产负债率 (%)18.18915.4619.6099.97913.965
带息债务/全部投入资本 (%)2.8940.4390.3260.2251.349
股东权益/带息债务 (%)3,202.07521,622.07029,248.73742,454.2846,972.824
股东权益/负债合计 (%)449.780546.770940.724902.103616.087
利息保障倍数 (X)166.702-110.556-17.324-17.835-26.683

营运能力分析
应收账款周转天数 (天)122.951100.24483.53782.23466.325
存货周转天数 (天)88.943186.287202.617161.925122.591